Phase I Trial of Dacomitinib Concomitant With Radiotherapy With and Without Cisplatin in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Dacomitinib (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2016 Results published in the Investigational New Drugs
- 09 Jun 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Sep 2015 as per ClinicalTrials.gov record.